Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating both early and late onset alopecia areata.

Microinfusion of methotrexate can help treat frontal fibrosing alopecia.

MOF controls key genes for skin development by regulating mitochondrial and ciliary functions.

Axitinib treatment turned a man's grey hair back to black.

The grand round helps improve diagnoses and suggests new treatments for hair disorders.

Minoxidil effectively improved hair loss in a teenage girl with androgenetic alopecia.

Since 1995, we only use Follicular Unit Transplantation for hair restoration and stopped using minigrafting/micrografting techniques.

Thymosin β4 and VEGF are important for organ function and may help with blood vessel formation.

sFRP4 partially inhibits hair regeneration, but the study needs clearer data analysis and better explanation of the process.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

ALRV5XR is the most effective hair regrowth treatment at 24 weeks.

Hairless mice have longer hair follicles and abnormal structures during the catagen phase.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

4-aminopyridine speeds up and improves skin wound healing.

A specific mutation in the TRPV3 gene causes hair follicle cells to develop improperly, leading to hair loss.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

Unable to provide a summary as no conclusion is provided in the text.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

A missing mK6irs1 gene causes hair loss in mice.

Scalp microinfusion is a new method for treating hair loss that shows promise but needs more research for standardization.

Thymosin β4 helps improve skin healing and reduce scarring.

M1 homeopathic complex may help slow melanoma cell growth.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

The study found that variations in hair protein genes are likely due to evolutionary deletions or duplications.